Latest filing published 04 Mar 2026 for Corbus Pharmaceuticals Holdings, Inc., €43k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Dominic Smethurst span 2 companies, the busiest being Corbus Pharmaceuticals Holdings, Inc. and BICYCLE THERAPEUTICS plc. The record holds 10 filings, for trades running from 23 September 2021 to 2 March 2026.
The open-market record consists of 4 sales worth €155k, with no purchase. Other entries cover 5 share grants and 1 option exercise. Since January 2026: no purchases and 2 sales on the market.
The newest entry dates from 4 March 2026: an open-market sale of €43k, in Corbus Pharmaceuticals Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations